AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway.
Yanjun GaoYingge LiZheming LiuYi DongSiqi YangBin WuMengxia XiaoChen ChenYingmei WenLei ChenHaijuan JiangYi YaoPublished in: Journal of hepatocellular carcinoma (2023)
AHSA1 might serve as a biomarker for predicting the clinical outcome of patients with HCC. It is vital in tumor metastasis and disease progression of HCC and may facilitate the development of clinical intervention strategies against HCC.